je.st
news
Valeant CEO 'disappointed' in Allergan poison pill: CNBC
2014-04-23 15:56:28| Biotech - Topix.net
T he chief executive officer of Valeant Pharmaceuticals, which made a $47 billion unsolicited offer for competitor Allergan Inc. on Tuesday, said during an interview on CNBC that he was "disappointed" with Allergan's so-called poison pill.
Tags: ceo
disappointed
pill
poison
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|